A functional heteromeric MIF receptor formed by CD74 and CXCR4

FEBS Letters

Volumn 583, Issue 17, 2009, Pages 2749-2757

  Schwartz, Verena ^a   Lue, Hongqi ^a   Kraemer, Sandra ^a   Korbiel, Joanna ^a   Krohn, Regina ^a   Ohl, Kim ^a   Bucala, Richard ^b   Weber, Christian ^a   Bernhagen, Jürgen ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD74; Chemokine receptor; CXCR4; GPCR; Invariant chain; MIF

Indexed keywords

CD74 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; LYMPHOCYTE ANTIGEN; MACROPHAGE MIGRATION INHIBITION FACTOR; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEK293; CELL SURFACE; COMPLEX FORMATION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CELL LINE; ENZYME ACTIVATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MONOCYTES; MULTIPROTEIN COMPLEXES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CXCR4; RECEPTORS, IMMUNOLOGIC; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 69249228563     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.07.058     Document Type: Article

References (43)

1. Calandra T., and Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 3 (2003) 791-800
2. Mitchell R.A., and Bucala R. Tumor growth-promoting properties of macrophage migration inhibitory factor. Semin. Cancer Biol. 10 (2000) 359-366
3. Morand E.F., Leech M., and Bernhagen J. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat. Rev. Drug Discov. 5 (2006) 399-410
4. Zernecke A., Bernhagen J., and Weber C. Macrophage migration inhibitory factor in cardiovascular disease. Circulation 117 (2008) 1594-1602
5. Bernhagen J., et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13 (2007) 587-596
6. Kamir D., et al. A Leishmania ortholog of macrophage migration inhibitory factor modulates host macrophage responses. J. Immunol. 180 (2008) 8250-8261
7. Charo I.F., and Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. New Engl. J. Med. 354 (2006) 610-621
8. Murphy P.M., et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52 (2000) 145-176
9. Sallusto F., and Baggiolini M. Chemokines and leukocyte traffic. Nat. Immunol. 9 (2008) 949-952
10. Thelen M., and Stein J.V. How chemokines invite leukocytes to dance. Nat. Immunol. 9 (2008) 953-959
11. Balabanian K., et al. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J. Biol. Chem. 280 (2005) 35760-35766
12. Vera P.L., Iczkowski K.A., Wang X., and Meyer-Siegler K.L. Cyclophosphamide-induced cystitis increases bladder CXCR4 expression and CXCR4-macrophage migration inhibitory factor association. PLoS One 3 (2008) e3898
13. Beider K., Abraham M., and Peled A. Chemokines and chemokine receptors in stem cell circulation. Front. Biosci. 13 (2008) 6820-6833
14. Degryse B., and de Virgilio M. The nuclear protein HMGB1, a new kind of chemokine?. FEBS Lett. 553 (2003) 11-17
15. Weber C., Kraemer S., Drechsler M., Lue H., Koenen R.R., Kapurniotu A., Zernecke A., and Bernhagen J. Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment. Proc. Natl. Acad. Sci. USA 105 (2008) 16278-16283
16. Leng L., et al. MIF signal transduction initiated by binding to CD74. J. Exp. Med. 197 (2003) 1467-1476
17. Stern L.J., Potolicchio I., and Santambrogio L. MHC class II compartment subtypes: structure and function. Curr. Opin. Immunol. 18 (2006) 64-69
18. Henne C., Schwenk F., Koch N., and Moller P. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens. Immunology 84 (1995) 177-182
19. Starlets D., et al. Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. Blood 107 (2006) 4807-4816
20. Shi X., et al. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25 (2006) 595-606
21. Bernhagen J., Mitchell R.A., Calandra T., Voelter W., Cerami A., and Bucala R. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration Inhibitory factor (MIF). Biochemistry 33 (1994) 14144-14155
22. Khalil H., Brunet A., and Thibodeau J. A three-amino-acid-long HLA-DRβ cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35. J. Cell Sci. 118 (2005) 4679-4687
23. Tarasova N.I., Stauber R.H., and Michejda C.J. Spontaneous and ligand-induced trafficking of CXC-chemokine receptor 4. J. Biol. Chem. 273 (1998) 15883-15886
24. Lue H., et al. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene 26 (2007) 5046-5059
25. Schober A., Bernhagen J., and Weber C. Chemokine-like functions of MIF in atherosclerosis. J. Mol. Med. 86 (2008) 761-770
26. Meyer-Siegler K.L., Iczkowski K.A., Leng L., Bucala R., and Vera P.L. Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J. Immunol. 177 (2006) 8730-8739
27. Zernecke A., Shagdarsuren E., and Weber C. Chemokines in atherosclerosis: an update. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 1897-1908
28. Busch R., Rinderknecht C.H., Roh S., Lee A.W., Harding J.J., Burster T., Hornell T.M., and Mellins E.D. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression. Immunol. Rev. 207 (2005) 242-260
29. Cresswell P. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12 (1994) 259-293
30. Lamb C.A., and Cresswell P. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. J. Immunol. 148 (1992) 3478-3482
31. Brachet V., Raposo G., Amigorena S., and Mellman I. Ii chain controls the transport of major histocompatibility complex class II molecules to and from lysosomes. J. Cell Biol. 137 (1997) 51-65
32. Weber C., and Koenen R.R. Fine-tuning leukocyte responses: towards a chemokine 'interactome'. Trends Immunol. 27 (2006) 268-273
33. Wetzker R., and Bohmer F.D. Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat. Rev. Mol. Cell Biol. 4 (2003) 651-657
34. Waters C.M., Connell M.C., Pyne S., and Pyne N.J. C-Src is involved in regulating signal transmission from PDGFbeta receptor-GPCR(s) complexes in mammalian cells. Cell Signal. 17 (2005) 263-277
35. Akekawatchai C., Holland J.D., Kochetkova M., Wallace J.C., and McColl S.R. Transactivation of CXCR4 by the insulin-like growth factor-1 receptor (IGF-1R) in human MDA-MB-231 breast cancer epithelial cells. J. Biol. Chem. 280 (2005) 39701-39708
36. Szaszak M., Chen H.D., Chen H.C., Baukal A., Hunyady L., and Catt K.J. Identification of the invariant chain (CD74) as an angiotensin AGTR1-interacting protein. J. Endocrinol. 199 (2008) 165-176
37. Naujokas M.F., Morin M., Anderson M.S., Peterson M., and Miller J. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell 74 (1993) 257-268
38. Nagasawa T., Tachibana K., and Kawabata K. A CXC chemokine SDF-1/PBSF: a ligand for a HIV coreceptor, CXCR4. Adv. Immunol. 71 (1999) 211-228
39. Nagasawa T., et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382 (1996) 635-638
40. Marsh L.M., Cakarova L., Kwapiszewska G., von Wulffen W., Herold S., Seeger W., and Lohmeyer J. Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair. Am. J. Physiol. Lung Cell Mol. Physiol. 296 (2009) L442-452
41. Moser B., and Loetscher P. Lymphocyte traffic control by chemokines. Nat. Immunol. 2 (2001) 123-128
42. Muller A., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001) 50-56
43. Ceradini D.J., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10 (2004) 858-864